Document:

Exhibit 10.2

 

To subscribe for Units

in the private offering of

AETHLON MEDICAL, INC.

 

	1.	Date and Fill in the number of units (the “Units”) (each Unit consisting of
(a) one hundred thousand (100,000) shares of the Company’s common stock par value $0.001 per share (the “Common Stock”)
at a purchase price of $0.125 per share, and (b) a five-year warrant (collectively, the “Warrants” and together with
the Units and Common Stock, the “Securities”) to purchase fifty thousand (50,000) shares of Common Stock of the Company
at an exercise price equal to $0.22 per share, subject to equitable adjustment thereunder (the “Exercise Price”) at
a negotiated price of $12,500 per Unit being subscribed for and Complete and Sign the Signature Page included in the Subscription
Agreement.

 

	2.	Initial the Accredited Investor Certification attached to this Subscription Agreement.

 

	3.	Complete and Sign the Signature Page attached to this Subscription Agreement. NOTICE:
Please note that by executing the attached Subscription Agreement, you will deemed to have executed the Unit Purchase Agreement
(Exhibit B to the Memorandum, as defined below), and agreed to the terms of the Warrant (Exhibit C to the Unit Purchase Agreement)
and all exhibits, supplements and schedules thereto, as such may be amended from time to time (collectively the “Transaction
Documents”), each of which are attached to the Memorandum, and will be treated for all purposes as if you did review, approve
and execute, if required, each such Transaction Document even though you may not have physically signed the signature pages to
such documents.

 

	4.	Complete and Return the attached Purchaser Questionnaire and, if applicable, Wire Transfer
Authorization attached to this Subscription Agreement.

 

	5.	Return all forms to your Account Executive and then send
                                 all signed original documents with a check (if applicable) to:

 

_________________

_________________

_________________

_________________

 

	6.	Please make your subscription payment payable to the order of “_________________, as Escrow
Agent for Aethlon Medical, Inc.” Account No. _________________

 

 

    	1

    	 

    

 

For wiring funds directly
to the escrow account, use the following instructions:

 

_________________

_________________

_________________

Acct. Name:

 

 

ABA Number:

SWIFT Code:

A/C Number:

 

FBO: Purchaser
Name

           Social
Security Number

           Address

 

 

 

 

 

 

 

 

 

ALL SUBSCRIPTION DOCUMENTS MUST BE FILLED
IN AND SIGNED EXACTLY AS SET FORTH WITHIN.

 

 

 

 

 

    	2

    	 

    

 

SUBSCRIPTION AGREEMENT

 

 

AETHLON MEDICAL, INC.

 

 

Aethlon Medical, Inc.

8910 University Center Lane, Suite 660

San Diego, California 92122

Attn: James A. Joyce, CEO

 

Ladies and Gentlemen:

 

1.          Subscription. The undersigned (the “Purchaser”) will purchase the number of units (collectively, the “Units”)
of securities of Aethlon Medical, Inc., a Nevada corporation (the “Company”), set forth
on the signature page to this Subscription Agreement, at a purchase price of $12,500 per Unit, with each Unit consisting
of (a) one hundred thousand (100,000) shares of the Company’s common stock par value $0.001 per share (the “Common
Stock”) at a purchase price of $0.125 per share, and (b) a five-year warrant (collectively, the “Warrants” and
together with the Units and Common Stock, the “Securities”) to purchase fifty thousand (50,000) shares of Common Stock
of the Company at an exercise price equal to $0.22 per share, subject to adjustment thereunder (the “Exercise Price”).
The Units are being offered (the “Offering”) by the Company
pursuant to the offering terms set forth in the Company’s Confidential Private Placement Memorandum, dated October 10, 2013,
as may be amended and/or supplemented, from time to time (collectively, the “Memorandum”).

 

The
Units are being offered on a “reasonable efforts, all or none” basis with respect to the minimum of $200,000 purchase
price for the Units (the “Minimum Offering”) and thereafter on a “reasonable efforts”
basis up to the maximum of $2,000,000 purchase price for the Units (the “Maximum Offering”).
The Units will be offered for sale until the earlier of (i) the date upon which subscriptions for the Maximum Offering
offered hereunder have been accepted, (ii) November 30, 2013 (subject to the right of the Company and the Placement Agent to extend
the offering until December 31, 2013 without further notice to investors), or (iii) the date upon which the Company and the Placement
Agent elect to terminate the Offering (the “Termination Date”).

 

The Company may hold an initial closing (“Initial
Closing”) at any time after the receipt of accepted subscriptions for the Minimum Offering. After the Initial Closing, subsequent
closings with respect to additional Securities may take place at any time prior to the Termination Date as determined by the Company,
with respect to subscriptions accepted prior to the Termination Date (each such closing, together with the Initial Closing, being
referred to as a “Closing”). The last Closing of the Offering, occurring on or prior to the Termination Date, shall
be referred to as the “Final Closing”. Any subscription documents or funds received after the Final Closing will be
returned, without interest or deduction. In the event that the any Closing does not occur prior to the Termination Date, all amounts
paid by the Purchaser shall be returned to the Purchaser, without interest or deduction.

 

    	3

    	 

    

 

Subscriptions for investment
below the minimum investment may be accepted at the discretion of the Placement Agent and the Company. The
Company reserves the right (but is not obligated) to have its employees, agents, officers, directors and affiliates purchase Units
in the Offering and all such purchases will be counted towards the Minimum Offering and the Maximum Offering. 

 

The terms of the Offering
are more completely described in the Memorandum and such terms are incorporated herein in their entirety. Certain capitalized terms
used, but not otherwise defined herein, will have the respective meanings provided in the Memorandum.

 

2.          Payment.
The Purchaser encloses herewith a check payable to, or will immediately make a wire transfer payment to, “_________________,
as Escrow Agent for Aethlon Medical, Inc.,” in the full amount of the purchase price of the Units being subscribed for.
Together with the check for, or wire transfer of, the full purchase price, the Purchaser is delivering a completed and executed
Signature Page to this Subscription Agreement along with a completed and executed Accredited Investor Certification, which are
annexed hereto. By executing this Subscription Agreement, you will be deemed to have executed the Unit Purchase
Agreement (Exhibit B to the Memorandum), and agreed to the terms of the Warrant (Exhibit C to the Memorandum) and all exhibits,
supplements and schedules thereto, as such may be amended from time to time (collectively the “Transaction Documents”),
each of which are attached to the Memorandum, and will be treated for all purposes as if you did review, approve and execute,
if required, each such Transaction Document even though you may not have physically signed the signature pages to such documents.

 

3.          Deposit
of Funds. All payments made as provided in Section 2 hereof will be deposited by the Purchaser as soon as practicable with
_________________, as escrow agent (the “Escrow Agent”), or such other escrow agent
appointed by ___________ and the Company, in a non-interest bearing escrow account (the “Escrow
Account”). In the event that the Company does not effect a Closing during the Offering Period, the Escrow Agent will refund
all subscription funds, without deduction and/or interest accrued thereon, and will return the subscription documents to each
Purchaser. If the Company or ___________ rejects a subscription, either in whole or in part
(at the sole discretion of the Company or ___________), the rejected subscription funds or the
rejected portion thereof will be returned promptly to such Purchaser without interest, penalty, expense or deduction.

 

4.          Acceptance
of Subscription. The Purchaser understands and agrees that the Company or ___________, each
in its sole discretion, reserves the right to accept this or any other subscription for the Units, in whole or in part, notwithstanding
prior receipt by the Purchaser of notice of acceptance of this or any other subscription. The Company will have no obligation hereunder
until the Company executes and delivers to the Purchaser an executed copy of the Purchase Agreement. If Purchaser’s subscription
is rejected in whole (at the sole discretion of the Company or ___________), the Offering is
terminated or the Minimum Offering is not subscribed for and accepted prior to the Termination Date, all funds received from the
Purchaser will be returned without interest, penalty, expense or deduction, and this Subscription Agreement will thereafter be
of no further force or effect. If Purchaser’s subscription is rejected in part (at the sole discretion of the Company or
___________) and the Company accepts the portion not so rejected, the funds for the rejected
portion of such subscription will be returned without interest, penalty, expense or deduction, and this Subscription Agreement
will continue in full force and effect to the extent such subscription was accepted. The Purchaser may revoke its subscription
and obtain a return of the subscription amount paid to the Escrow Account at any time before the date of the Initial Closing. The
Purchaser may not revoke this subscription or obtain a return of the subscription amount paid to the Escrow Agent on or after the
date of the Initial Closing. Any subscription received after the Initial Closing but prior to the Termination Date shall be irrevocable.

 

    	4

    	 

    

 

5.          Representations
and Warranties of the Purchaser. The Purchaser hereby acknowledges, represents, warrants, and agrees as follows:

 

(a)          None of the Units, the Common
Stock, the Warrants or the shares of Common Stock of the Company issuable upon exercise of the Warrants (collectively referred
to hereafter as the “Securities”) are registered under the Securities Act of 1933, as amended (the “Securities
Act”), or any state securities laws. The Purchaser understands that the offering and sale of the Securities is intended to
be exempt from registration under the Securities Act, by virtue of Section 4(2) thereof and the provisions of Regulation D promulgated
thereunder, based, in part, upon the representations, warranties and agreements of the Purchaser contained in this Subscription
Agreement and the Purchase Agreement;

 

(b)          The Purchaser and the Purchaser’s
attorney, accountant, purchaser representative and/or tax advisor, if any (collectively, “Advisors”), have received
and have carefully reviewed the Memorandum, this Subscription Agreement, and each of the Transaction Documents and all other documents
requested by the Purchaser or its Advisors, if any, and understand the information contained therein, prior to the execution of
this Subscription Agreement;

 

(c)          Neither the Securities and Exchange
Commission (the “Commission”) nor any state securities commission has approved or disapproved of the Securities or
passed upon or endorsed the merits of the Offering or confirmed the accuracy or determined the adequacy of the Memorandum. The
Memorandum has not been reviewed by any Federal, state or other regulatory authority. Any representation to the contrary may be
a criminal offense;

 

(d)          All documents, records, and
books pertaining to the investment in the Securities including, but not limited to, all information regarding the Company and the
Securities, have been made available for inspection and reviewed by the Purchaser and its Advisors, if any;

 

(e)          The Purchaser and its Advisors,
if any, have had a reasonable opportunity to ask questions of and receive answers from the Company’s officers and any other
persons authorized by the Company to answer such questions, concerning, among other related matters, the Offering, the Securities,
the Transaction Documents and the business, financial condition, results of operations and prospects of the Company and all such
questions have been answered by the Company to the full satisfaction of the Purchaser and its Advisors, if any;

 

    	5

    	 

    

 

(f)          In evaluating the suitability
of an investment in the Company, the Purchaser has not relied upon any representation or other information (oral or written) other
than as stated in the Memorandum;

 

(g)          The Purchaser is unaware of,
is in no way relying on, and did not become aware of the offering of the Securities through or as a result of, any form of general
solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication published
in any newspaper, magazine or similar media or broadcast over television, radio or over the Internet, in connection with the offering
and sale of the Securities and is not subscribing for the Securities and did not become aware of the Offering through or as a result
of any seminar or meeting to which the Purchaser was invited by, or any solicitation of a subscription by, a person not previously
known to the Purchaser in connection with investments in securities generally;

 

(h)          The
Purchaser has taken no action which would give rise to any claim by any person for brokerage commissions, finders’ fees
or the like relating to this Subscription Agreement or the transactions contemplated hereby (other than fees to be paid by the
Company to ___________, as described in the Memorandum);

 

(i)          The Purchaser, either alone
or together with its Advisors, if any, has such knowledge and experience in financial, tax, and business matters, and, in particular,
investments in securities, so as to enable it to utilize the information made available to it in connection with the Offering to
evaluate the merits and risks of an investment in the Securities and the Company and to make an informed investment decision with
respect thereto;

 

(j)          The
Purchaser is not relying on the Company, ___________ or any of their respective employees or
agents with respect to the legal, tax, economic and related considerations of an investment in any of the Securities and the Purchaser
has relied on the advice of, or has consulted with, only its own Advisors;

 

(k)          The Purchaser is acquiring the
Securities solely for such Purchaser’s own account for investment and not with a view to resale or distribution thereof,
in whole or in part. The Purchaser has no agreement or arrangement, formal or informal, with any person to sell or transfer all
or any part of any of the Securities and the Purchaser has no plans to enter into any such agreement or arrangement;

 

(l)          The Purchaser understands and
agrees that purchase of the Securities is a high risk investment and the Purchaser is able to afford an investment in a speculative
venture having the risks and objectives of the Company. The Purchaser must bear the substantial economic risks of the investment
in the Securities indefinitely because none of the Securities may be sold, hypothecated or otherwise disposed of unless subsequently
registered under the Securities Act and applicable state securities laws or an exemption from such registration is available. Legends
will be placed on the certificates representing the Common Stock, the Warrants and the shares of Common Stock issuable upon exercise
of the Warrants to the effect that such securities have not been registered under the Securities Act or applicable state securities
laws and appropriate notations thereof will be made in the Company’s books;

 

    	6

    	 

    

 

(m)          The Purchaser has adequate means
of providing for such Purchaser’s current financial needs and foreseeable contingencies and has no need for liquidity from
its investment in the Securities for an indefinite period of time;

 

(n)          The Purchaser is aware that
an investment in the Securities involves a number of very significant risks and has carefully read and considered the Company's
periodic filings with the United States Securities and Exchange Commission, and the matters set forth in the Memorandum and, in
particular, the matters under the caption “Risk Factors” therein and understands any of such risk may materially adversely
affect the Company’s operations and future prospects;

 

(o)          At
the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises
any Warrants, it will be an “accredited investor” within the meaning of Regulation D, Rule
501(a), promulgated by the Securities and Exchange Commission under the Securities Act and has truthfully and accurately completed
the Purchaser Questionnaire attached to this Subscription Agreement and will submit to the Company such further assurances of
such status as may be reasonably requested by the Company; 

 

(p)          The Purchaser: (i) if a natural
person, represents that the Purchaser has reached the age of 21 and has full power and authority to execute and deliver this Subscription
Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof; (ii) if a corporation,
partnership, or limited liability company, or association, joint stock company, trust, unincorporated organization or other entity,
represents that such entity was not formed for the specific purpose of acquiring the Securities, such entity is duly organized,
validly existing and in good standing under the laws of the state of its organization, the consummation of the transactions contemplated
hereby is authorized by, and will not result in a violation of state law or its charter or other organizational documents, such
entity has full power and authority to execute and deliver this Subscription Agreement and all other related agreements or certificates
and to carry out the provisions hereof and thereof and to purchase and hold the Securities, the execution and delivery of this
Subscription Agreement has been duly authorized by all necessary action, this Subscription Agreement has been duly executed and
delivered on behalf of such entity and is a legal, valid and binding obligation of such entity; or (iii) if executing this Subscription
Agreement in a representative or fiduciary capacity, represents that it has full power and authority to execute and deliver this
Subscription Agreement in such capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation,
or limited liability company or partnership, or other entity for whom the Purchaser is executing this Subscription Agreement, and
such individual, partnership, ward, trust, estate, corporation, or limited liability company or partnership, or other entity has
full right and power to perform pursuant to this Subscription Agreement and make an investment in the Company, and represents that
this Subscription Agreement constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this
Subscription Agreement will not violate or be in conflict with any order, judgment, injunction, agreement or controlling document
to which the Purchaser is a party or by which it is bound;

 

    	7

    	 

    

 

(q)          The
Purchaer hereby acknowledges receipt and careful review of this Agreement, the Memorandum, the Warrant and all other exhibits,
annexes and appendices thereto (collectively referred to as the “Offering Materials”), and has had access to the Company’s
Annual Report on Form 10-K and the exhibits thereto for the fiscal year ended March 31, 2013 (the “Form 10-K”), the
Company’s Quarterly Report on Form 10-Q and the exhibits thereto for the quarterly period ended June 30, 2013 (the “Form
10-Q”) and all subsequent periodic and current reports filed with the United States Securities and Exchange Commission (the
“SEC”) as publicly filed with and available at the website of the SEC which can be accessed at www.sec.gov, and hereby
represents that the Purchaser has been furnished by the Company during the course of the Offering with all information regarding
the Company, the terms and conditions of the Offering and any additional information that the Purchaser has requested or desired
to know, has been afforded the opportunity to ask questions of and receive answers from duly authorized officers or other representatives
of the Company concerning the Company and has been provided any such additional information by the
Company in writing to the full satisfaction of the Purchaser, if any;

 

(r)          The Purchaser represents to
the Company that any information which the undersigned has heretofore furnished or is furnishing herewith to the Company is complete
and accurate and may be relied upon by the Company in determining the availability of an exemption from registration under Federal
and state securities laws in connection with the offering of securities as described in the Memorandum;

 

(s)          The Purchaser has significant
prior investment experience, including investment in non-listed and unregistered securities. The Purchaser has a sufficient net
worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The Purchaser’s overall
commitment to investments which are not readily marketable is not excessive in view of the Purchaser’s net worth and financial
circumstances and the purchase of the Securities will not cause such commitment to become excessive. This investment is a suitable
one for the Purchaser;

 

(t)          The Purchaser is satisfied that
it has received adequate information with respect to all matters which it or its Advisors, if any, consider material to its decision
to make this investment;

 

(u)          The Purchaser acknowledges that
any and all estimates or forward-looking statements or projections included in the Memorandum were prepared by the Company in good
faith, but that the attainment of any such projections, estimates or forward-looking statements cannot be guaranteed, will not
be updated by the Company and should not be relied upon;

 

(v)          No oral or written representations
have been made, or oral or written information furnished, to the Purchaser or its Advisors, if any, in connection with the offering
of the Securities which are in any way inconsistent with the information contained in the Memorandum;

 

(w)          Within five (5) days after receipt
of a request from the Company, the Purchaser will provide such information and deliver such documents as may reasonably be necessary
to comply with any and all laws and ordinances to which the Company is subject;

 

    	8

    	 

    

 

(x)          THE SECURITIES OFFERED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF CERTAIN STATES AND ARE BEING OFFERED AND SOLD IN RELIANCE
ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY
AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID ACT AND SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION
THEREFROM. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER
REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY
OR ADEQUACY OF THE MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

(y)          In making an investment
decision, investors must rely on their own examination of Company and the terms of the Offering, including the merits and risks
involved. Investors should be aware that they will be required to bear the financial risks of this investment for an indefinite
period of time;

 

(z)          (For ERISA plans only)
The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been informed of and
understands the Company’s investment objectives, policies and strategies, and that the decision to invest “plan assets”
(as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan
assets and impose other fiduciary responsibilities. The Purchaser or Plan fiduciary (a) is responsible for the decision to invest
in the Company; (b) is independent of the Company and any of its affiliates; (c) is qualified to make such investment decision;
and (d) in making such decision, the Purchaser or Plan fiduciary has not relied on any advice or recommendation of the Company
or any of its affiliates; and

 

(aa)          The Purchaser has read in its
entirety the Memorandum and all exhibits and annexes thereto, including, but not limited to, all information relating to the Company,
and the Securities, and understands fully to its full satisfaction all information included in the Memorandum including, but not
limited to, the Section entitled “Risk Factors”.

 

(bb)          The
Purchaser represents that (i) the Purchaser was contacted regarding the sale of the Securities by the Company or the Placement
Agent (or another person whom the Purchaser believed to be an authorized agent or representative thereof) with whom the Purchaser
had a prior substantial pre-existing relationship and (ii) it did not learn of the offering of the Securities by means of any
form of general solicitation or general advertising, and in connection therewith, the Purchaser did not (A) receive or review
any advertisement, article, notice or other communication published in a newspaper or magazine or similar media or broadcast over
television or radio, whether closed circuit, or generally available; or (B) attend any seminar meeting or industry investor conference
whose attendees were invited by any general solicitation or general advertising.

 

    	9

    	 

    

 

(cc)          The Purchaser
consents to the placement of a legend on any certificate or other document evidencing the Securities and, when issued, the shares
of Common Stock issuable upon exercise of the Warrants (the “Warrant Shares”), that such securities have not been registered
under the Securities Act or any state securities or “blue sky” laws and setting forth or referring to the restrictions
on transferability and sale thereof contained in this Agreement. The Purchaser is aware that the Company will make a notation in
its appropriate records with respect to the restrictions on the transferability of such Securities. The legend to be placed on
each certificate shall be in form substantially similar to the following:

 

“THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE
SECURITIES OR “BLUE SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT
AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY
HAS RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

(dd)          The Purchaser
acknowledges that if he or she is a Registered Representative of a Financial Industry Regulatory Authority (“FINRA”)
member firm, he or she must give such firm the notice required by the FINRA’s Rules of Fair Practice, receipt of which must
be acknowledged by such firm prior to an investment in the Securities.

 

(ee)          To effectuate
the terms and provisions hereof, the Purchaser hereby appoint the Placement Agent as its attorney-in-fact (and the Placement Agent
hereby accepts such appointment) for the purpose of carrying out the provisions of the Escrow Agreement by and between the Company,
the Placement Agent and _________________ (the “Escrow Agreement”) including, without limitation, taking any action
on behalf of, or at the instruction of, the Purchaser and executing any release notices required under the Escrow Agreement and
taking any action and executing any instrument that the Placement Agent may deem necessary or advisable (and lawful) to accomplish
the purposes hereof. All acts done under the foregoing authorization are hereby ratified and approved and neither the Placement
Agent nor any designee nor agent thereof shall be liable for any acts of commission or omission, for any error of judgment, for
any mistake of fact or law except for acts of gross negligence or willful misconduct. This power of attorney, being coupled with
an interest, is irrevocable while the Escrow Agreement remains in effect.

 

(ff)          The Purchaser
agrees not to issue any public statement with respect to the Offering, Purchaser’s investment or proposed investment in the
Company or the terms of any agreement or covenant between them and the Company without the Company’s prior written consent,
except such disclosures as may be required under applicable law.

 

    	10

    	 

    

 

(gg)          The Purchaser
understands, acknowledges and agrees with the Company that this subscription may be rejected, in whole or in part, by the Company,
in the sole and absolute discretion of the Company, at any time before any Closing notwithstanding prior receipt by the Purchaser
of notice of acceptance of the Purchaser’s subscription.

 

(hh)          The Purchaser
acknowledges that the information contained in the Offering Materials or otherwise made available to the Purchaser is confidential
and non-public and agrees that all such information shall be kept in confidence by the Purchaser and neither used by the Purchaser
for the Purchaser’s personal benefit (other than in connection with this subscription) nor disclosed to any third party for
any reason, notwithstanding that a Purchaser’s subscription may not be accepted by the Company; provided, however, that (a)
the Purchaser may disclose such information to its affiliates and advisors who may have a need for such information in connection
with providing advice to the Purchaser with respect to its investment in the Company so long as such affiliates and advisors have
an obligation of confidentiality, and (b) this obligation shall not apply to any such information that (i) is part of the public
knowledge or literature and readily accessible at the date hereof, (ii) becomes part of the public knowledge or literature and
readily accessible by publication (except as a result of a breach of this provision) or (iii) is received from third parties without
an obligation of confidentiality (except third parties who disclose such information in violation of any confidentiality agreements
or obligations, including, without limitation, any subscription or other similar agreement entered into with the Company).

 

(ii)          The Purchaser
understands that Rule 144 promulgated under the Act (“Rule 144”) requires, among other conditions, a minimum holding
period of six-months prior to the resale of securities acquired in a non-public offering without having to satisfy the registration
requirements under the Act. The Purchaser understands and hereby acknowledges that the Company is under no obligation to register
the Securities under the Act or any state securities or “blue sky” laws or to assist the Purchaser in obtaining an
exemption from various registration requirements, other than as set forth herein.

 

6.          Representations and Warranties
of the Company.

 

7.          Indemnification.
The Purchaser agrees to indemnify and hold harmless the Company, ___________ and each of
their respective officers, directors, managers, employees, agents, attorneys, control persons and affiliates from and against
all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not limited to, any and all expenses
incurred in investigating, preparing or defending against any litigation commenced or threatened) based upon or arising out of
any actual or alleged false acknowledgment, representation or warranty, or misrepresentation or omission to state a material fact,
or breach by the Purchaser of any covenant or agreement made by the Purchaser herein or in any other document delivered in connection
with this Subscription Agreement or any other Transaction Document.

 

    	11

    	 

    

 

8.          Binding Effect. This Subscription
Agreement will survive the death or disability of the Purchaser and will be binding upon and inure to the benefit of the parties
and their heirs, executors, administrators, successors, legal representatives, and permitted assigns. If the Purchaser is more
than one person, the obligations of the Purchaser hereunder will be joint and several and the agreements, representations, warranties
and acknowledgments herein will be deemed to be made by and be binding upon each such person and such person’s heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

9.          Modification. This Subscription
Agreement will not be modified or waived except by an instrument in writing signed by the party against whom any such modification
or waiver is sought.

 

10.          Notices. Any notice or
other communication required or permitted to be given hereunder will be in writing and will be mailed by certified mail, return
receipt requested, or delivered by reputable overnight courier such as FedEx against receipt to the party to whom it is to be given
(a) if to the Company, at the address set forth in the Purchase Agreement or (b) if to the Purchaser, at the address set forth
on the signature page hereof (or, in either case, to such other address as the party will have furnished in writing in accordance
with the provisions of this Section 10). Any notice or other communication given by certified mail will be deemed given
at the time of certification thereof, except for a notice changing a party’s address which will be deemed given at the time
of receipt thereof. Any notice or other communication given by overnight courier will be deemed given at the time of delivery.

 

11.          Assignability. This Subscription
Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the Purchaser and the transfer
or assignment of any of the Securities will be made only in accordance with all applicable laws.

 

12.          Applicable
Law.  This Subscription Agreement will be governed by and construed under the laws of the State of New York as applied to
agreements among New York residents entered into and to be performed entirely within New York. The parties hereto (1) agree that
any legal suit, action or proceeding arising out of or relating to this Subscription Agreement
will be instituted exclusively in New York State Supreme Court, County of New York, or in the United States District Court for
the Southern District of New York, (2) waive any objection which the parties may have now or hereafter to the venue of any such
suit, action or proceeding, and (3) irrevocably consent to the jurisdiction of the New York State Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each
of the parties hereto further agrees to accept and acknowledge service of any and all process which may be served in any such
suit, action or proceeding in the New York State Supreme Court, County of New York, or in the United States District Court for
the Southern District of New York and agrees that service of process upon it mailed by certified mail to its address will be deemed
in every respect effective service of process upon it, in any such suit, action or proceeding. THE PARTIES HERETO AGREE, TO THE
EXTENT PERMITTED BY APPLICABLE LAW, TO WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON
OR ARISING OUT OF THIS SUBSCRIPTION AGREEMENT OR ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY.

 

    	12

    	 

    

 

13.          Blue Sky Qualification.
The purchase of Securities pursuant to this Subscription Agreement is expressly conditioned upon the exemption from qualification
of the offer and sale of the Securities from applicable federal and state securities laws.

 

14.          Use of Pronouns. All
pronouns and any variations thereof used herein will be deemed to refer to the masculine, feminine, neuter, singular or plural
as the identity of the person or persons referred to may require.

 

15.          Confidentiality. The
Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or about the Company not otherwise
properly in the public domain, was received in confidence. The Purchaser agrees not to divulge, communicate or disclose, except
as may be required by law or for the performance of this Subscription Agreement, or use to the detriment of the Company or for
the benefit of any other person or persons, or misuse in any way, any confidential information of the Company, including any trade
or business secrets of the Company and any business materials that are treated by the Company as confidential or proprietary, including,
without limitation, confidential information obtained by or given to the Company about or belonging to third parties.

 

16.          Miscellaneous.

 

(a)          This Subscription Agreement,
together with the other Transaction Documents, constitute the entire agreement between the Purchaser and the Company with respect
to the subject matter hereof and supersede all prior oral or written agreements and understandings, if any, relating to the subject
matter hereof. The terms and provisions of this Subscription Agreement may be waived, or consent for the departure therefrom granted,
only by a written document executed by the party entitled to the benefits of such terms or provisions.

 

(b)          Each of the Purchaser’s
and the Company’s representations and warranties made in this Subscription Agreement will survive the execution and delivery
hereof and delivery of the Securities.

 

(c)          Each of the parties hereto will
pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others engaged by such party) in
connection with this Subscription Agreement and the transactions contemplated hereby whether or not the transactions contemplated
hereby are consummated.

 

(d)          This Subscription Agreement
may be executed in one or more counterparts each of which will be deemed an original, but all of which will together constitute
one and the same instrument.

 

(e)          Each provision of this
Subscription Agreement will be considered separable and, if for any reason any provision or provisions hereof are determined to
be invalid or contrary to applicable law, such invalidity or illegality will not impair the operation of or affect the remaining
portions of this Subscription Agreement.

 

    	13

    	 

    

 

(f)          Paragraph titles are for descriptive
purposes only and will not control or alter the meaning of this Subscription Agreement as set forth in the text.

 

17.          Signature
Page. It is hereby agreed by the parties hereto that the execution by the Purchaser of this Subscription Agreement,
in the place set forth hereinbelow, will be deemed and constitute the agreement by the Purchaser to be bound by all of the terms
and conditions hereof as well as by the Unit Purchase Agreement and each of the other Transaction Documents, and will be deemed
and constitute the execution by the Purchaser of all such Transaction Documents without requiring the Purchaser’s separate
signature on any of such Transaction Documents.

 

 

 

 

 

[Remainder of page intentionally left
blank.]

 

 

 

 

 

 

 

 

 

 

 

    	14

    	 

    

 

ANTI-MONEY LAUNDERING REQUIREMENTS

 

 

 

 

 

	
        The USA PATRIOT Act

         

         

         
	What is money laundering?	How big is the problem and why is it important?
	
         

         

        The USA PATRIOT Act is designed to detect, deter, and punish
        terrorists in the United States and abroad. The Act imposes new anti-money laundering requirements on brokerage firms and financial
        institutions. Since April 24, 2002 all brokerage firms have been required to have new, comprehensive anti-money laundering programs.

         

        To help you understand theses efforts, we want to provide you
        with some information about money laundering and our steps to implement the USA PATRIOT Act.

         
	
         

         

        Money laundering is the process of disguising illegally obtained
        money so that the funds appear to come from legitimate sources or activities. Money laundering occurs in connection with a wide
        variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.

         
	
         

         

        The use of the U.S. financial system by criminals to facilitate
        terrorism or other crimes could well taint our financial markets. According to the U.S. State Department, one recent estimate puts
        the amount of worldwide money laundering activity at $1 trillion a year.

         

 

 

	What are we required to do to eliminate money laundering?
	
         

         

        Under new rules required by the USA PATRIOT Act, our anti-money
        laundering program must designate a special compliance officer, set up employee training, conduct independent audits, and establish
        policies and procedures to detect and report suspicious transaction and ensure compliance with the new laws.

         
	
         

         

        As part of our required program, we may ask you to provide various
        identification documents or other information. Until you provide the information or documents we need, we may not be able to effect
        any transactions for you.

         

 

 

    	15

    	 

    

 

AETHLON MEDICAL,
INC.

SIGNATURE PAGE TO

SUBSCRIPTION AGREEMENT

 

Purchaser hereby elects to purchase
a total of ______Unit(s) at a purchase price of $12,500 per Unit (NOTE: to be completed by the Purchaser).

 

Date (NOTE: To be completed by the Purchaser):
__________________, 2013

 

If the
Purchaser is an INDIVIDUAL, and if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

  

	____________________________	______________________________
	Print Name(s)	Social Security Number(s)
	 	 
	___________________________	______________________________
	Signature(s) of Purchaser(s)	Signature
	 	 
	____________________________	______________________________
	Date	Address

 

If the
Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or TRUST:

 

	____________________________	______________________________
	Name of Partnership,	Federal Taxpayer
	Corporation, Limited 	Identification Number
	Liability Company or Trust	 
	 	 
	By:_________________________	______________________________
	      Name:	State of Organization
	      Title:	 
	 	 
	____________________________	______________________________
	Date	Address

 

AGREED AND ACCEPTED:

 

AETHLON MEDICAL, INC.

  

	By:__________________________	_________________
	      Name:	Date
	      Title:	 

 

    	16

    	 

    

 

AETHLON MEDICAL, INC.

ACCREDITED INVESTOR CERTIFICATION

 

For Individual Investors Only

(All individual investors must INITIAL
where appropriate. Where there are joint investors both parties must INITIAL):

 

Initial
_______     I certify that I have a “net worth” of at least $1 million either individually or through aggregating
my individual holdings and those in which I have a joint, community property or other similar shared ownership interest with my
spouse. For purposes of calculating net worth under this paragraph, (i) the primary residence shall not be included as an asset,
(ii) to the extent that the indebtedness that is secured by the primary residence is in excess of the fair market value of the
primary residence, the excess amount shall be included as a liability, and (iii) if the amount of outstanding indebtedness that
is secured by the primary residence exceeds the amount outstanding 60 days prior to the execution of this Subscription Agreement,
other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability.

 

Initial
_______     I certify that I have had an annual gross income for the past two years of at least $200,000
(or $300,000 jointly with my spouse) and expect my income (or joint income, as appropriate) to reach the same level in the current
year.

 

 

For Non-Individual
Investors

(all Non-Individual
Investors must INITIAL where appropriate):

 

Initial
_______    The undersigned certifies that it is a partnership, corporation, limited liability company or business trust that
is 100% owned by persons who meet either of the criteria for Individual Investors, above.

 

Initial
_______    The undersigned certifies that it is a partnership, corporation, limited liability company or business trust that
has total assets of at least $5 million and was not formed for the purpose of investing in Company.

 

Initial
_______    The undersigned certifies that it is an employee benefit plan whose investment decision is made by a plan fiduciary
(as defined in ERISA §3(21)) that is a bank, savings and loan association, insurance company or registered investment adviser.

 

Initial
_______    The undersigned certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date
of the Subscription Agreement.

 

Initial
_______    The undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely
by persons who meet either of the criteria for Individual Investors, above.

 

Initial
_______    The undersigned certifies that it is a U.S. bank, U.S. savings and loan association or other
similar U.S. institution acting in its individual or fiduciary capacity.

 

Initial
_______    The undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange
Act of 1934.

 

Initial
_______    The undersigned certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with
total assets exceeding $5,000,000 and not formed for the specific purpose of investing in Company.

 

Initial
_______    The undersigned certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific
purpose of investing in Company, and whose purchase is directed by a person with such knowledge and experience in financial and
business matters that he is capable of evaluating the merits and risks of the prospective investment.

 

Initial
_______    The undersigned certifies that it is a plan established and maintained by a state or its political subdivisions,
or any agency or instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.

 

Initial
_______    The undersigned certifies that it is an insurance company as defined in §2(a)(13) of the Securities Act of
1933, as amended, or a registered investment company.

 

    	17

    	 

    

 

AETHLON MEDICAL, INC.

Purchaser
Questionnaire

(Must be completed by Purchaser)

 

 

Section A - Individual Purchaser
Information

 

Purchaser Name(s): ________________________________________________________________________

 

Individual executing Profile or Trustee: _______________________________________________________________________

 

Social Security Numbers / Federal I.D. Number: ________________________________________________________________________

 

Date of Birth: _________________ Marital Status: _________________

 

Joint Party Date of Birth:_________________

Investment Experience (Years): ___________

 

Annual Income: _________________ 

Liquid Net Worth:____________

 

Net Worth: ________________

 

Investment Objectives (circle
one or more):     Long Term Capital Appreciation, Short Term Trading, Businessman’s Risk, Income, Safety of Principal,
Tax Exempt Income or other

 

Home Street Address: ________________________________________________________________________

 

Home City, State & Zip Code: ________________________________________________________________________

 

Home Phone: ________________________ Home Fax: _____________________

 

Home Email: _______________________________

 

Employer: ________________________________________________________________________

 

Employer Street Address: ________________________________________________________________________

 

Employer City, State & Zip Code: ________________________________________________________________________

 

Bus. Phone: __________________________ Bus. Fax: _______________________

 

Bus. Email: ________________________________

 

Type of Business: ________________________________________________________________________

 

___________ Account
Executive / Outside Broker/Dealer: _______________________________________________________

 

Please check if you are a FINRA
member or affiliate of a FINRA member firm: _______

 

    	18

    	 

    

 

AETHLON
MEDICAL, INC.

Purchaser
Questionnaire

(Must be completed by Purchaser)

 

 

Section B – Entity Purchaser
Information

 

Purchaser Name(s): ________________________________________________________________________

 

Authorized Individual executing Profile or Trustee: _______________________________________________________________________

 

Social Security Numbers / Federal I.D. Number: ________________________________________________________________________

 

Investment Experience (Years): ___________

 

Annual Income: _______________ 

 

Net Worth: ________________

 

Was the Entity formed for the specific purpose of purchasing
the Common Stock and Warrants? [  ] Yes [  ] No

 

Principal Purpose (Trust)______________________________________

 

Type of Business: ________________________________________________________

 

Investment Objectives (circle
one or more):     Long Term Capital Appreciation, Short Term Trading, Businessman’s Risk, Income, Safety of Principal,
Tax Exempt Income or other

 

Street Address: ________________________________________________________________________

 

City, State & Zip Code: ________________________________________________________________________

 

Phone: ________________________ Fax: ________________________

 

Email: __________________________

 

___________ Account
Executive / Outside Broker/Dealer: 

 

_______________________________________________________

 

Please check if you are a FINRA
member or affiliate of a FINRA member firm: _______

 

 

    	19

    	 

    

 

Section C – Form of Payment
– Check or Wire Transfer

 

 

____ Check payable to “_________________,
AS ESCROW AGENT FOR AETHLON MEDICAL, INC.

 

____ Wire funds from my outside account
according to the “To subscribe for Units of Common Stock and Warrants to Purchase
Shares of Common Stock in the private offering of AETHLON MEDICAL, INC.” 

 

____ Wire funds from my _________________
Account – See following page

 

____ The funds
for this investment are rolled over, tax deferred from ____________________ within the Allowed 60-day window

 

 

Section D – Purchaser Instructions
for Payments of any Dividends

 

[  ] Please
make any dividend and any other payment checks pursuant to the Units to “_________________ c/f [Insert Client
Name]” and deliver such checks to _________________ so
that they may deposit them into my _________________ brokerage account

 

[  ] Please make out any dividend and any
other payment checks pursuant to the Units in the registered name of the Purchaser set forth in the signature page to
the Subscription Agreement for the Units and mail such checks to me at the address specified in such signature page

 

 

Section E – Securities Delivery
Instructions (check one)

 

____ Please deliver my securities
to _________________ for deposit into my brokerage account.

 

____ Please deliver my securities to the address listed in the
above Purchaser Questionnaire.

 

____ Please deliver my securities to the below address:

_________________

_________________

_________________

_________________

 

Purchaser Signature(s): _______________________________________Date:_______________

 

    	20

    	 

    

 

Wire Transfer Authorization

 

	TO:	OPERATIONS MANAGER
	 	_________________
	 	 
	RE:	Client Wire Transfer Authorization
	 	AETHLON MEDICAL, INC.
	 	 
	DATE:	________________

 

 

 

This
memorandum authorizes the transfer of the following listed funds from my _________________ Brokerage
Account as follows:

 

_________________ Brokerage Account #    ______________________

 

Wire Amount     $______________________

 

_________________

_________________

_________________

 

ABA Number: 

For
Credit to _________________, as Escrow Agent for 

Aethlon Medical,
Inc.

Account No.: 

 

 

REFERENCE:

 

PURCHASER'S LEGAL NAME     ______________________________________________________

 

TAX ID NUMBER    ______________________________________________________

 

PURCHASER'S ADDRESS    ______________________________________________________

 

FBO: ________________________________________________

 

 

Signature:________________________________________________

 

Signature:________________________________________________

       (Joint Signature)

 

 

    	21Exhibit 10.1

 

 

 

    	1

    	 

    

 

EXHIBIT A

 

 

	Class and Number	And	Percentage Vote Required	Class and Number	And	Percentage Vote Required
	Membership Interests	 	90%	Common Stock	 	No Vote is required under Section 1201
    of the California Corporations Code
	100,000	 	90%	65,570,296	 	 
	 	 	 	 	 	 
	 	 	 	Preferred Stock And Series A Preferred
    Stock	 	No Vote is required under Section 1201
    of the California Corporations Code
	 	 	 	No Shares are issued or outstanding	 	 

 

    	2

    	 

    

 

 

AGREEMENT OF MERGER

 

THIS AGREEMENT OF
MERGER (this “Agreement”) is entered into as of October 28, 2013, by and among Sustainable Environmental Technologies
Corporation, a California corporation (“Subsidiary”) and HJG Holdings, LLC, a California limited liability company
(“Parent”)

 

Subsidiary and Parent
hereby agree that at the Effective Time (as defined in this Agreement), Subsidiary and will merge into Parent on the following
terms and conditions (the “Merger”):

 

ARTICLE 1

MERGER

 

At the Effective Time
(as defined below), Subsidiary will be merged with and into Parent. Parent will be the surviving entity (hereinafter sometimes
called the “Surviving Entity”). At the Effective Time, the separate corporate existence of Subsidiary will cease,
and Surviving Entity will assume and succeed to the assets, rights, properties, privileges, powers, immunities, liabilities and
obligations of Subsidiary. All rights of creditors and all liens on the property of Subsidiary will be preserved unimpaired, but
limited to the property affected by such rights or liens immediately before the Merger.

 

ARTICLE 2

EFFECTIVE DATE

 

The Merger provided
for in this Agreement will become effective on the filing by and in the office of the California Secretary of State of an executed
copy of this Agreement with all requisite accompanying certificates. The time of such filing is referred to in this Agreement as
the “Effective Time.”

 

ARTICLE 3

ARTICLES OF INCORPORATION; BYLAWS; BOARD
OF DIRECTORS; OFFICERS

 

3.1Articles
of Organization. Parent’s articles of organization in effect immediately before the Effective Time will remain the articles
of organization of the Surviving Entity without change or amendment until they are duly altered, amended, or repealed.

 

3.2Operating
Agreement. Parent’s Operating Agreement in effect immediately before the Effective Time will remain as the Operating
Agreement of the Surviving Entity without change or amendment until they are duly altered, amended, or repealed in accordance thereto.
Subsidiary’s bylaws shall become null and void and of no further effect as of the Effective Time.

 

3.3Directors
and Officers. At the Effective Time, the directors of the Subsidiary shall resign from such appointment. The officer(s) of
Subsidiary then in office immediately before the Effective Time will become officers, in the same capacity that they serve Subsidiary,
of the Surviving Entity, and will continue as officers of the Surviving Entity in such capacities until such time as their successor
has been elected and qualified as provided for in the articles of organization and Operating Agreement of the Surviving Entity.

 

    	3

    	 

    

 

ARTICLE 4

CONVERSION OF SHARES

 

In and by virtue of
the Merger, the shares of stock of Subsidiary’s common stock outstanding at the Effective Time will be converted as follows:

 

4.1Conversion
of Subsidiary’s Common Stock. At the Effective Time, each outstanding share of Subsidiary’s common stock, $0.001
par value, (“Subsidiary Common Stock”), excluding any shares of Subsidiary Common Stock not issued and outstanding
at the Effective Time, will, by virtue of the Merger and without any further action on the part of Parent, Subsidiary, Surviving
Entity, or the shareholders of Subsidiary, shall be converted into and become the right to receive from Parent the sum of $0.11
per share in cash, without interest.

 

Upon Subsidiary’s
shareholders surrender to Broadridge Financial Solutions, who shall act as a payment agent as more specifically described in the
Letter attached hereto on Exhibit “B”, on or after the effective date of the Merger, of Subsidiary Common Stock
certificates properly endorsed or otherwise in a proper form for transfer, together with delivery of an executed letter of transmittal,
Parent will pay to the shareholder $0.11 per share in cash promptly after the Effective Time (subject to reduction and/or increase
in accordance with the escrow fund provisions).

 

Parent has designated
Broadridge Financial Solutions, as the will payment agent (the “Payment Agent”). Promptly after the Effective
Time, Buyer will take all steps necessary to enable and cause the Surviving Entity to provide the Payment Agent with funds necessary
to make the payments provided for by the terms of this Agreement. Promptly after the Effective Time, the Surviving Corporation
will cause the Payment Agent to mail a letter of transmittal to each person who is shown as a shareholder of record of Subsidiary
Common Stock immediately before the Effective Time. The letter of transmittal will be substantially in the form of Exhibit “B”
to this Agreement. Upon delivery and surrender to the Payment Agent of the holder’s executed letter of transmittal and certificate(s)
evidencing ownership of Target Common Stock, the holder will be entitled to receive in exchange therefor an amount in cash equal
to the product of the number of shares of Target Common Stock represented by such certificate(s) multiplied by $0.11, less applicable
withholding taxes (as provided below). All such certificates will be canceled. No interest will be paid, payable, or accrued on
the amount of cash payable to any person hereunder. Each Target shareholder shall be deemed to have contributed such shareholder’s
pro rata portion of the Escrow Account. The amount of cash payable to any shareholder of Target shall be subject to, and reduced
by an amount equal to, the amount of any state, federal, and foreign withholding taxes incurred (and not previously paid by or
on behalf of such shareholder).

 

4.2The preceding
paragraph of this article will not apply to any shares of Subsidiary Common Stock that constitute “dissenting shares”
within the meaning of California Corporations Code §1300(b). The holders of such shares will have, in consideration for the
cancellation of dissenting shares held by them, the rights given to them under the applicable provisions of the California General
Corporation Law, including the right to receive the fair market value of those shares, in the manner and subject to the procedures
and conditions provided by law.

 

4.3From and after
the Effective Time, no transfer of Subsidiary Common Stock outstanding before the Effective Time will be made on the record books
of Subsidiary.

 

4.4Subsidiary’s
Preferred Stock; Series A Preferred Stock. There are no shares of Preferred Stock or Series A Preferred Stock of Subsidiary
issued or outstanding. Therefore, there will be no disposition of the Preferred Stock or Series A Preferred Stock.

 

    	4

    	 

    

 

ARTICLE 5

TERMINATION

 

This Agreement may
be terminated at any time before the Effective Time (whether before or after approval) by action of the shareholders of Subsidiary
or by the mutual consent and action of the boards of directors of Subsidiary and Parent.

 

ARTICLE 6

MISCELLANIOUS

 

6.1Further
Instruments and Assurances. The Parties will execute and deliver all such other and further instruments and documents as may
be necessary or desirable to carry out the purposes of this Agreement, including but not limited to the filing of the final tax
return for Subsidiary and merger documentation with the California Secretary of State.

 

6.2Invalidity
and Severability. If any provisions of this Agreement are held to be invalid or unenforceable, such invalidity or unenforceability
shall not affect the other provisions of this Agreement which are intended to be, and shall be deemed, severable.

 

6.3Assignment
and Binding Effect. No Party shall assign this Agreement to any extent without the written consent of the other Parties hereto.
Subject to the forgoing, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors
and assigns.

 

6.4Amendments
and Waiver. This Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively) only with the written consent of all of the Parties hereto.

 

6.5Governing
Law. This Agreement shall be governed by and construed under the internal laws of the State of California, without reference
to principles of conflict of laws or choice of laws.

 

6.6Counterparts.
This Agreement and any amendments hereto may be executed in any number of counterparts, all of which taken together shall constitute
a single original instrument. In any action or proceeding any photographic, photo static or other copy of this Agreement may be
entered into evidence.

 

6.7Entire Agreement.
This Agreement, together with all exhibits and schedules hereto, constitutes the entire agreement and understanding of the parties
with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings,
duties or obligations between the parties with respect to the subject matter hereof.

 

6.8Headings.
The headings in this Agreement are inserted for convenience only and are in no way intended to describe, interpret, define, or
limit the scope, extent or intent of this Agreement or any provision of this Agreement.

 

6.9Appendices,
Schedules and Exhibits. All references in this Agreement to appendices, exhibits and schedules shall, unless otherwise expressly
provided, be deemed to be references to the appendices, exhibits and schedules attached to this Agreement. All such appendices,
exhibits and schedules attached to this Agreement are incorporated into this Agreement as though fully set forth in this Agreement.

 

    	5

    	 

    

 

 

6.10Interpretation.
This Agreement is the product of negotiation and shall be deemed to be drafted by all of the Parties hereto and shall not be construed
in favor of any particular Party, but shall be construed neutrally and by the plain meaning of its language. Each Party executing
this Agreement represents and warrants that he or it does so with full knowledge of his or its rights, having a full opportunity
to undertake whatever discovery or investigation he or it desired, and after receiving independent legal advice from his or its
attorneys with respect to the agreements herein and all rights which are herein settled. Each Party further warrants, represents
and agrees that he or it has not relied upon any representation or statement of fact or opinion by any other Party, their agents
or attorneys.

 

6.11Signer’s Warranty. Each signatory to this Agreement represents and warrants that he or it
has the fully authority to make and enter into this Agreement.

 

 

IN WITNESS WHEREOF,
the Parties have caused this Agreement to be executed and delivered as to the date first above written.

 

	 	 	
        SUSTAINABLE ENVIRONMENTAL TECHNOLOGIES CORPORATION,

        a California corporation
	 
	 	 		 
	 	By:	Keith Morlock	 
	 	Its:	Chief Executive Officer	 
	 	 	 	 
	 	 	
        HJG HOLDINGS, LLC,

        a California limited liability company
	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 		 
	 	By:	Horst Geicke	 
	 	Its:	President	 

 

 

    	6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]